MITF and melanoma: This trajectory model corroborated the proliferative-invasive model, showing a gradual reduction in expression of the melanoma master transcription factor MITF, and a corresponding increase in expression of genes prognostic for treatment resistance such as the receptor tyrosine kinase AXL and the growth factor receptor EGFR [1, 9].